Standard VA module lipid-lowering therapies in solid organ transplantations pose challenges due to interactions with immunosuppressants.Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) represent a new class of lipid-lowering therapies with potential promise in this population.We describe Bathroom Cleaners PCSK9i as an efficacious and safe option for management of hypercholesterolemia in solid organ transplantations.(Level of Difficulty: Advanced.).